AI Article Synopsis
- A study was conducted on 68 Thoroughbred racehorses to investigate the impact of a single dose of enrofloxacin (ERFX) on their health after long-distance transport.* -
- Horses in the ERFX group (n=52) received an IV dose before a 21-hour transport, while the control group (n=16) received saline.* -
- Results indicated that the ERFX group had significantly lower fever, white blood cell counts, and serum amyloid A levels compared to controls, suggesting ERFX effectively prevents transportation-related fever in these horses.*
Article Abstract
To evaluate the effects of single-dose enrofloxacin (ERFX) on fever and blood properties in 68 Thoroughbred racehorses after long-distance transportation, horses were assigned to receive ERFX (5 mg/kg, IV; ERFX group; n=52) or saline (0.9% NaCl) solution (50 ml, IV; control group; n=16) ≤1 hr before transportation. Horses were transported 1,122 km using commercial vans over the course of approximately 21 hr. Clinical examinations and hematologic analyses were performed before and after transportation. Rectal temperatures, white blood cell counts and serum amyloid A concentration of ERFX group were significantly lower than control group (P<0.01, P<0.01 and P<0.05, respectively). In conclusion, these results show ERFX administration just before transportation is effective at preventing transportation-associated fever in adult Thoroughbred racehorses.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383162 | PMC |
| http://dx.doi.org/10.1292/jvms.16-0465 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!